DXCM Q1 2022 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$629M+24.5% YoY

Gross Profit

$398M63.3% margin

Operating Income

$41M6.6% margin

Net Income

$97M15.5% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

-9.9%

Cash Flow

Operating Cash Flow

$71M

Free Cash Flow

-$31M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$5.1B

Total Liabilities

$2.9B

Stockholders' Equity

$2.2B

Cash & Equivalents

$716M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$629M	$505M	+24.5%
Gross Profit	$398M	$344M	+15.8%
Operating Income	$41M	$46M	-10.0%
Net Income	$97M	$40M	+141.4%

Geographic Segments

UNITED STATES

$451M72%

Non-US

$178M28%